Guizzetti Leonardo
Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.
Pediatr Blood Cancer. 2016 Oct;63(10):1713-22. doi: 10.1002/pbc.26106. Epub 2016 Jun 14.
To compare the clinical effectiveness of total splenectomy (TS) or partial splenectomy (PS) in pediatric hereditary spherocytosis, a systematic review and meta-analysis was performed (PROSPERO registration CRD42015030056). There were 14 observational studies comparing pre- and postoperative hematologic parameters. Secondary outcomes include in-hospital infections, surgical complications, symptomatic recurrence, and biliary disease. TS is more effective than PS to increase hemoglobin (3.6 g/dl vs. 2.2 g/dl) and reduce reticulocytes (12.5% vs. 6.5%) after 1 year; outcomes following PS are stable for at least 6 years. There were no cases of overwhelming postsplenectomy sepsis. A population-based patient registry is needed for long-term follow-up.
为比较全脾切除术(TS)与部分脾切除术(PS)治疗小儿遗传性球形红细胞增多症的临床疗效,我们进行了一项系统评价和荟萃分析(PROSPERO注册号CRD42015030056)。有14项观察性研究比较了术前和术后的血液学参数。次要结局包括住院期间感染、手术并发症、症状复发和胆道疾病。全脾切除术在术后1年提高血红蛋白水平(3.6 g/dl对2.2 g/dl)和降低网织红细胞水平(12.5%对6.5%)方面比部分脾切除术更有效;部分脾切除术后的结局至少6年保持稳定。未发生暴发性脾切除术后感染。需要建立一个基于人群的患者登记系统进行长期随访。